ArticleBlood advances2018

Activation of MYC, a bona fide client of HSP90, contributes to intrinsic ibrutinib resistance in mantle cell lymphoma.

Jimmy Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.